GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Purchase Of Business

Waverley Pharma (TSXV:WAVE) Purchase Of Business : C$0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Purchase Of Business?

Waverley Pharma's purchase of business for the three months ended in Sep. 2024 was C$0.00 Mil. It means Waverley Pharma spent C$0.00 Mil on purchasing business. Waverley Pharma's purchase of business for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Mar. 2024 ), Waverley Pharma spent the same money on purchasing business in Sep. 2024 (C$0.00 Mil).


Waverley Pharma Purchase Of Business Historical Data

The historical data trend for Waverley Pharma's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Purchase Of Business Chart

Waverley Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Business
Get a 7-Day Free Trial - - - - -

Waverley Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Waverley Pharma Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waverley Pharma Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Waverley Pharma Business Description

Traded in Other Exchanges
Address
1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6
Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Bortezomib, Pemetrexed, Capecitabine, and Temozolomide, among others.
Executives
Haaris Uddin Senior Officer
Albert David Friesen 10% Security Holder, Director, Senior Officer
Theron Edwin Odlaug Senior Officer